New malaria vaccine to be piloted in 2018
As the world celebrates World Malaria Day, there’s news that three African countries will pilot a potential solution to a lethal problem
BRAZZAVILLE, CONGO — As the world celebrates World Malaria Day, the World Health Organization (WHO) has announced Ghana, Kenya and Malawi will pilot a US$49.2-million malaria vaccine program in 2018.
“Information gathered in the pilot will help us make decisions on the wider use of this vaccine,” says Dr Matshidiso Rebecca Moeti, WHO regional director for Africa. “Combined with existing malaria interventions, such a vaccine would have the potential to save tens of thousands of lives in Africa.”
The injectable RTS,S vaccine — developed by the U.K.-based GSK, a global healthcare company — is expected to protect children from the most lethal strain of malaria caused by the Plasmodium falciparum parasite.
Although there’s been a 62 percent decrease in malaria-related deaths in the past 15 years, approximately 429,000 people died from it in 2015 — the majority of whom lived in Africa — reports WHO.
Christian Children’s Fund of Canada aims to reduce the risk of malaria through the distribution of mosquito nets and other related medicine in the countries where we work, including Ghana. To learn more, visit ccfcanada.ca/gift-catalogue.
Christian Children’s Fund of Canada:
Christian Children’s Fund of Canada (CCFC) is a child-centred international development organization and a member of ChildFund Alliance. For more than 55 years, CCFC has worked with children, communities, donors and other partners — changing lives through improved health, education and clean water. CCFC works in 12 countries across Africa, Asia and the Americas, to support more than 700,000 children, youth and community members.